News & Updates

Dementia is an important risk factor for coronavirus disease 2019 (COVID-19) outcomes in community-dwelling older adults, with its effect becoming stronger with increasing patient age, a recent study has found.

Treatment with sotrovimab reduces the risk of all-cause hospitalization or death in patients with COVID-19 who are at high risk of progression to severe disease, regardless of anti-SARS-CoV-2 serostatus, according to a study presented at CROI 2022.

Oral health has been mildly compromised during the coronavirus disease 2019 (COVID-19) pandemic, particularly among people who have been infected and those suffering from depression, anxiety, and psychological stress, a recent study reported.

Most patients with inflammatory bowel disease (IBD) build an initial immune response to SARS-CoV-2 vaccination, but older patients, those treated with antitumour necrosis factor (anti-TNF) and an immunomodulator, and those on corticosteroids may require an additional vaccine dose to achieve better immunity against COVID-19, according to a study.

Use of oral antibiotics in the treatment of osteomyelitis, bacteraemia, and infective endocarditis results in shorter hospital stay, has a better safety profile, and appears to be similarly effective when compared to intravenous (IV)-only therapy, a recent study has shown.

Strong family resilience may help lessen the psychological consequences of the coronavirus disease 2019 (COVID-19), according to a recent Singapore study.

The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is more stable than the ancestral strain on various smooth and porous surfaces and demonstrates marked resistance to neutralizing monoclonal antibodies (mAbs), researchers from the University of Hong Kong (HKU) have reported.

Older adults in long-term care facilities see a rapid drop in antibody titres over the first 6 months after the second dose of the BNT162b2 vaccine for the coronavirus disease 2019 (COVID-19), reports a recent study.